Stay updated on Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe study page now shows that enrollment has ended and adds helpful sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment header formatting and records a version bump from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check16 days agoChange DetectedThe page now shows Revision: v3.5.5, updating the site version from v3.5.4. This reflects a general platform update applied to the page footer.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates a newer revision of the page metadata associated with an updated release of the document.SummaryDifference0.0%

- Check52 days agoChange DetectedIn the Taiwan locations list, the Taoyuan District entry was removed and replaced with Taoyuan, Taiwan, 333, preserving the same site code. This reflects a standardization of the city name in the study's locations.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a minor technical update with no change to the displayed study record content.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.